NeurogesX Shares Rise Following FDA Approval
NeurogesX shares rise as Food and Drug Administration approves Qutenza pain patch
12:42PM 11/17/09
NeurogesX Gets FDA Approval For Pain Patch
NeurogesX receives Food and Drug Administration approval for Qutenza pain patch
06:03PM 11/16/09
Biotech Calendar: Key Dates for November
Your quick-and-dirty guide to key dates and events for biotech investors during November.
07:12AM 11/02/09
CEO Sells $10.8M Worth of Guess
Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.
09:43AM 09/18/09
NeurogesX Names Board Member, Meets Nasdaq Rules
NeurogesX said it named Bradford Goodwin to board, regaining compliance with Nasdaq rules
11:33AM 08/25/09
Biotech Calendar: Key FDA Action Dates
A quick and dirty guide to upcoming FDA approval dates for biotech drugs.
11:57AM 08/05/09
Biotech's Hot and Getting Hotter
July and August are traditionally slow months on the biotech calendar. But not this year as biotech firms, both big and small, release results from clinical trials or await FDA decisions.
08:57AM 08/03/09
Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.
09:21AM 07/17/09
Harbinger Sells $10.3M Worth of Calpine
Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.
09:06AM 07/16/09
Director Sells $425K Worth of Royal Gold
Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.
10:49AM 07/09/09
Insider Sells $5.8M Worth of Adtran
Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.
10:01AM 07/02/09
NeurogesX, FDA Agree On Qutenza Study
NeurogesX to perform small, add-on study of Qutenza following agreement with FDA
11:53AM 06/10/09
Biotech Calendar: Key FDA Action Dates
A quick and dirty guide to upcoming FDA approval dates for biotech drugs.
12:07PM 06/03/09
Here's a look back at the hits, misses and notable moments from 2008.
12:20PM 12/29/08
Biotech Mailbag: NeurogesX Patchy at Best
It's not clear how this tiny biotech's pain patch can compete with a host of rivals, large and small.
01:01PM 12/05/08



Connect with TheStreet